A randomised phase II double blind placebo controlled trial of Whole Brain RadioTherapy (WBRT) and Tarceva (OSI-774, erlotinib) in patients with advanced Non-Small Cell Lung Cancer (NSCLC) with multiple brain metastases

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2007
This article has no abstract
Epistemonikos ID: ddc4da68f3231cb8a41d29ee674137d73c7ca8d9
First added on: Jan 17, 2025